Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity (Q40110666)

17 September 2017

title

Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity (English)

1 reference

17 September 2017

0 references

1 reference

1 reference

Sirirat Klongpanichapak

1

1 reference

17 September 2017

Pansiri Phansuwan-Pujito

2

1 reference

17 September 2017

Manuchair Ebadi

3

1 reference

17 September 2017

Piyarat Govitrapong

4

1 reference

17 September 2017

language of work or name

1 reference

1 August 2007

1 reference

Journal of Pineal Research

17 September 2017

published in

1 reference

17 September 2017

volume

43

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

65-73

1 reference

Dual effect of sodium nitroprusside on potentials recorded from mouse hippocampal slices.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Is methamphetamine abuse a risk factor in parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Oxidative stress and antioxidant therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Toxin-induced models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

A review of neuroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin, mitochondria, and cellular bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin mitigates mitochondrial malfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Ubiquitin-immunoreactive structures in the midbrain of methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin neutralizes neurotoxicity induced by quinolinic acid in brain tissue culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin relieves the neural oxidative burden that contributes to dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin is protective against MPTP-induced striatal and hippocampal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00444.X

10.1111/J.1600-079X.2007.00444.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference